<DOC>
	<DOCNO>NCT02068404</DOCNO>
	<brief_summary>Preterm birth lead cause perinatal mortality morbidity . According WHO , 15 million child bear prematurely ( gestational age &lt; 37 week ) world year 7 % die complication associate prematurity . Despite constant improvement obstetrical care , number preterm birth increase last decade prematurity still frequent cause prenatal hospitalization industrialize country . The American College Obstetricians Gynecologists well Royal College Obstetricians Gynaecologists recommend nifedipine first-line tocolytic case acute threaten preterm labour . Clinical experience show however important variability treatment response among pregnant woman . In spite large use obstetrics tocolytic agent , nifedipine prescribe off-label . As consequence international consensus optimal dose schedule far propose . Small sample size heterogeneousness tocolysis administration protocol make difficult compare little data available pharmacokinetics nifedipine pregnant woman . Nevertheless important interindividual variability concentration identify ( CV=12-76 % ) study investigate possible reason variability pregnant woman . Genetic environmental factor involve drug distribution metabolism ( e.g . enzymatic activity , CYP 3A5 genotype ) might partially explain variability drug level therefore difference treatment response . The goal study quantify variability nifedipine pharmacokinetics identify potential genetic non-genetic source variability nifedipine pharmacokinetics pregnant woman . The relationship concentration treatment response evaluate serve propose optimal dosage regimen improve efficacy reduce side effect associate treatment .</brief_summary>
	<brief_title>Nifedipine Pharmacokinetics Pharmacodynamics When Used Tocolytic Acute Threatened Preterm Labour</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Tocolytic Agents</mesh_term>
	<criteria>Pregnant woman nifedipine treatment acute threaten preterm labour Hospitalization condition maternity University Hospital Lausanne ( CHUV ) Gestational age 2034 week Signed informed consent Patient &lt; 18 year Contraindication tocolysis clinical reason ( e.g . severe preeclampsia , chorioamnionitis , placental anomaly , letal fetal anomaly , important intrauterine growth restriction ) current labour Contraindication nifedipine Severe renal hepatic impairment Fever &gt; 37.5Â°C Incapacity communication</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Tocolysis</keyword>
	<keyword>Preterm labor</keyword>
	<keyword>Nifedipine</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>